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Aim. To determine cytotoxic effects towards a tumor cells culture of the heterocyclic deriva-
tive conjugated with lectins of different carbohydrate specificity. Methods. Conjugation of 
lectins (Pea seeds (PSA), peanuts (PNA) and erythroagglyutinin from bean seeds (PHA-E) 
with thiopyrano[2,3-d]thiazole Les-1895, biotesting these conjugates in the cell culture. 
Results. The conjugates of Les-1895 with specific lectins posses increased cytotoxic effects 
towards Jurkat cells — by 23 % for PSA-Les-1895, 34 % for PNA-Les-1895, and by 12 % 
for PHA-E-Les-1895. IC50 of Les-1895 conjugates was ≈ 10 μg/ml, whereas at using free 
Les-1895 — it was ≈ 30 μg/ml. The PNA and PHA-E conjugates with Les-1895 suppressed 
the viability of HCT 116 cells more considerably than the PSA conjugate. A cytotoxic action 
of PNA (IC50 = 4 μg/ml) and PHA-E (IC50 = 3 μg/ml) conjugates was more pronounced than 
the effect of free Les-1895 (IC50 = 10 μg/ml) or intact lectins. The conjugation of Les-1895 
with human serum albumin (HSA) increased the water solubility, however, such conjugation 
decreased the cytotoxic effect towards Jurkat cells by 40 %. The pseudonormal cells line HEK 
293 was less sensitive to the action of native lectins — PSA, PNA and PHA-E as well as to 
the action of conjugates of these lectins. Conclusions. Conjugation of Les-1895 with specific 
lectins enhanced a cytotoxic effect. The obtained results suggest a possibility of the addresed 
delivery of biologically active compounds to specific cells of tissues and organs of the human 
body.
K e y w o r d s: pea lectin, peanut lectin, FGA-R, conjugates, thiopyrano[2,3-d]thiazoles, anti-
tumor activity.
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Introduction
Various thiopyrano[2,3-d]thiazole derivatives 
with the anticancer, antiviral, anti-inflamma-
tory, antimicrobial and antitrypanosomal ac-
tivities were synthezized at the Department of 
the Pharmaceutical, Organic and Bioorganic 
Chemistry of Danylo Halytsky Lviv National 
Medical University [1]. A pharmaceutical po-
tential of these derivatives can be significant-
ly increased through the development of water 
soluble forms that also creates the conditions 
for their selective binding to the biological 
targets. In previous study [2], we have conju-
gated pea seeds lectin in the alkaline medium 
(pH 9.0) with the thiopyrano[2,3-d]thiazole 
derivative through the interaction of the alde-
hyde group of this compound with the amino 
groups of amino acids of the lectins. The bio-
logical activity of obtained conjugates towards 
the mouse leukemia cells of L1210 line was 
evaluated. It was shown that the obtained con-
jugates had a 2.5-fold increased antineoplastic 
effect (calculated as the amount of substance 
conjugated to the lectin) compared to the non-
conjugated compound. It was assumed that 
such enhancement is caused by a selective 
interaction of lectin with certain types of cells 
in tissues. Thus, a targeted delivery of the 
substance to potential sites of its action is pos-
sible. The application of lectin conjugates with 
drugs might also have some disadvantages. 
The main one is a protein nature of the lectin 
carrier which can cause allergic reactions, 
especially after its direct administration into 
the bloodstream. At the same time, such con-
jugates could be useful at external application 
into the body cavities (oral or nasal) or as 
rectal suppositories. The advantage of lectins 
as drug carriers compared to the synthetic 
polymers is lectins biodegradability. There are 
numerous literature data describing commer-
cially available lectins selectively binding to 
normal or pathological tissues. It has been 
established that peanut lectin (PNA) selec-
tively binds the T-antigen present in 71 % of 
cancer cells and not detected by the monoclo-
nal antibodies in healthy donors [3, 4]. Our 
investigation on binding capacity of the PNA-E 
receptors with colon cancer cells revealed that 
PNA-E interacted with the adenoma cells and 
with adenocarcinomas of high degree of dif-
ferentiation. This lectin possesses a higher 
selectivity to the adenoma cells compared to 
the tumor cells with a low degree of differen-
tiation. Thus, the lectin binding can be used as 
a selective histochemical marker of these pa-
thologies [5], as well as for the targeted deli-
very of drugs to the specific colon cells. 
Therefore, the next step of our work was to 
investigate the action of such conjugates on 
the cells of other lines, in particular, the 
T-lymphoblastic leukemia Jurkat cells, HCT 
116 line of human colorectal carcinoma cells, 
and HEK 293 pseudonormal cells of human 
embryonic kidney. In this study, thiopyrano[2,3-
d]thiazole derivative (Les-1895) [6] was used 
as an adduct attached to the lectins.
Materials and Methods
In Fig. 1, one can see a schematic reaction of 
the thiopyrano[2,3-d]thiazole derivative (Les-
1895) conjugation with lectins isolated from 
the pea seeds (PSA, Pisum sativum agglutinin), 
peanut seeds (PNA, peanut agglutinin), and 
erythroagglutinin of the common bean 
(PHA-E). In control, Les-1895 was conju-
gated to human serum albumin (HSA). These 
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conjugations were accomplished through the 
aldehyde group of Les-1895 interacting with 
the amino groups of amino acids of lectins 
under the alkaline conditions (pH 9.0).
Conjugation. 10 mg of lectin or HSA were 
dissolved in 1.0 ml of 1 % aqueous solution 
of sodium bicarbonate with addition of 0.025-
0.2 ml of 1 % solution of Les-1895 in DMSO. 
The obtained solution was stirred and kept for 
3 h at room temperature. After stirring the 
turbid solution was gradually highlighted, 5 
mg of sodium borohydride were added to the 
solution and the obtained mixture was kept for 
12 h. To separate the unreacted Les-1895 from 
its conjugate, the mixture was dialyzed against 
50 ml of 20 % aqueous solution of DMSO, 
and then against 50 ml of phosphate buffered 
saline (PBS).
Investigation of the obtained conjugate. The 
obtained conjugate was characterized for its 
lectin activity measured as an ability to bind 
specific carbohydrates and glycoproteins of the 
plasma membrane. The content of protein and 
Les-1895 attached to the lectin was also cal-
culated. The lectin’s activity before and after 
conjugation was measured by determining the 
agglutination titer of 2 % rabbit erythrocyte 
suspension in PBS. The concentration of Les-
1895 in the conjugate was determined by mea-
suring the absorbance at 361 nm wavelength, 
where this compound has a characteristic 
maximum of absorption (Fig. 2). The content 
of total protein was measured using Lowry 
method with an absorbance at 740 nm.
Synthesis of Les-1895. Synthesis of 
7-[4-(benzyloxy)phenyl]-2-oxo-3,5,6,7-tetra-
hydro-2H-thiopyrano[2,3-d][1,3]thiazole-
6-carbaldehyde (Les-1895) was accomplished 
in the [4+2]-cyclocondensation reaction of 
5 - ( 4 - b e n z y l o x y  b e n z y l i d e n e ) - 4 -
thioxothiazolidinone-2 as a heterodiene and 
acrolein as a dienophile under the refluxing for 
1 h with a catalytic amount of the hydroqui-
none in a glacial acetic acid medium [6].
Cell culture. The human colorectal carci-
noma HCT 116 cells, T-lymphoblastic leukemia 
Jurkat cells, and pseudonormal human embry-
onic kidney HEK 293 cells were obtained from 
Cell culture collection at R.E. Kavetsky Institute 
of Experimental Pathology, Oncology and 
Lectin-NH2
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+
S
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S
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Fig. 1. Conjugation of Les-1895 with lectins.
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Radiobiology, National Academy of Sciences 
of Ukraine (Kyiv). The HEK 293 cells were 
cultured in the Dulbecco’s -modified Eagle’s 
medium (DMEM, Sigma, USA) in the presence 
of 10 % of the decomposed blood serum of 
cattle embryos, using phenol red as an indicator 
of pH, and 50 μg/ml of gentamicin antibiotic 
(Sigma, USA). The cells of Jurkat and HCT 116 
lines were cultured in the RPMI-1640 (Thermo 
scientific, USA) medium in the presence of 
10 % decomposed blood serum of cattle em-
bryos, phenol red, and 50 μg/ml of gentamicin 
(Sigma, USA). To evaluate cytotoxicity of the 
lectins (PSA, PNA, PHA-E), Les-1895, and the 
conjugates with these lectins, the appropriate 
samples were added in different concentrations 
to the medium in which the cells are cultured. 
After 24 h, the number of cells was counted in 
the hemocytometric chamber using the Trypan 
blue dye (DV-T10282, “Invitrogen”, USA) that 
penetrates through the plasma membrane of the 
damaged (dead) cells. The cells colored in blue 
were considered as the necrotic ones. The num-
ber of cells in suspension was calculated ac-
cording to the formula: с = 12500n, where: 
c — the number of cells in 1 ml of suspension, 
n — the average number of cells in 5 large 
squares of the hemocytometer chamber. The 
evaluation of cytotoxicity and antiproliferative 
activity of the tested compound was carried out 
after 72 h of incubation using the MTT assay. 
The cell viability was evaluated by measuring 
Fig. 2. Absorption spectrum of Les-1895 (0.03 % solution in DMSO).
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a reduction of the MTT dye (3-(4,5-dimethyl-
thiazol-2-yl)-2,5-diphenyltetrazolium bromide) 
(Sigma, USA) to water-insoluble formazan 
which has a purple color.
Statistical analysis. Each experiment was 
performed in triplicate and average values 
were recorded. The data were evaluated statis-
tically using Student’s t-test, and a value of 
p ≤ 0.05 was considered to be statistically 
reliable. 
Results and Discussion
Les-1895 is soluble only in organic solvents 
such as dimethyl sulfoxide or dimethylfor-
mamide. Here we demonstrated that the con-
jugation of this compound with the lectin (see 
Materials and Methods section) led to creation 
of the water soluble product.
Comparing to the previously reported 
thiopyrano[2,3-d]thiazole derivative, Les-1351 
[2], an increase of the amount of  Les-1895 in 
the reaction mixture up to 1 mg per 10 mg of 
pea lectin (10 %) did not lead to the lectin 
inactivation. Noteworthy, Les-1895 present in 
the reaction mixture was not completely im-
mobilized on lectin. According to our calcula-
tions, 10 mg of lectin bound 0.9 mg of Les-
1895 (9 % of total weight of the conjugate). 
Similar results were obtained for PNA and 
PHA-E, where 10 mg of PNA bound maximum 
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Fig. 3. The results of measuring the cytotoxic effect (Trypan blue exclusion test) of Les-1895, specific lectins, and 
their conjugates towards human T-lymphoblastic leukemia Jurkat cells. The cytotoxic activity of the conjugates (Les-
1895 + PSA, PNA, PHA-E or HSA) was calculated taking into account the amount of the attached Les-1895.
* p < 0.05; ** p<0.01; *** p<0.001
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0.5 mg of Les-1895 (5 % of total mass of the 
conjugate), and 10 mg of PHA-E bound 8 % 
of Les-1895 of total mass of the conjugate. At 
the same time, 10 mg of HSA could bind up 
to 1.6 mg Les-1895 (16 % of the total conju-
gate mass). The obtained conjugates of lectins 
with Les-1895 were soluble in water, phos-
phate buffered saline (PBS), and 1 % NaHCO3 
solution, whereas the initial Les-1895 com-
pound was practically insoluble in these media.
Unlike the murine leukemia L1210 cells [2] 
that were insensitive to the pea lectin (PSA), 
the T-lymphoblastic leukemia Jurkat cells were 
subjected to a cytotoxic action of the PHA-E 
and PNA lectins. IC50 for PNA and PSA was 80 
and 37 μg/ml, respectively, and for PHA-E — 
20 μg/ml. IC50 for Les-1895 was 32 μg/ml. 
According to these data, PHA-E was more ef-
fective in targeting Jurkat cells than Les-1895. 
The conjugates of the lectins with this com-
pound displayed a cytotoxic effect towards the 
T-lymphoblastic leukemia Jurkat cells — 23 % 
inhibition for PSA-Les-1895, 34 % — for PNA-
Les-1895, and 12 % — for PHA-E-Les-1895. 
IC50 of the conjugates of lectins with Les-1895 
was 10 μg/ml, whereas IC50 of free Les-1895 
compound was 30 μg/ml. Though the conjuga-
tion of Les-1895 to HSA increased a water 
solubility of Les 1895, it at the same time re-
duced by 40 % a cytotoxic effect of the obtained 
conjugate towards the T-lymphoblastic leuke-
mia Jurkat cells (Fig. 3).
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Fig. 4. The results of measuring cytotoxicity (Trypan blue exclusion test)  of Les-1895, specific lectins, and their con-
jugates towards the human colorectal carcinoma cells of HCT 116 line.
* p < 0.05; ** p<0.01; *** p<0.001
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Noteworthy, PNA and PHA-E significantly 
suppressed the viability of human colorectal 
carcinoma HCT116 cells comparing to the ef-
fects of intact HSA and pea lectin. The cyto-
toxic action of the Les-1895 conjugates with 
the PNA and PHA-E lectins was more potent 
than the action of free Les-1895 and non-
conjugated lectins. IC50 of the PSA-Les-1895 
conjugate was 28 μg/ml, PNA-Les-1895 — 
4 μg/ml, and PHA-E-Les-1895 — 3 μg/ml. 
IC50 of Les-1895 was approximately 10 μg/ml, 
whereas the cytotoxic effect of the HSA-E-
Les-1895 and the PSA-Les-1895 conjugates 
was weaker than that of free Les-1895 (Fig. 4).
Pseudonormal human embryonic kidney 
HEK 293 cells were insensitive to the action 
of PSA, PNA and PHA-E lectins, and at 30 
mg/ml dose of these lectins there were ≈20 % 
of dead cells. The conjugation of Les-1895 
with these lectins did not significantly enhance 
their cytotoxic effect as compared to the action 
of the Les-1895 free form (Fig. 5).
Taking into account the obtained results, one 
can suggest a positive correlation between the 
level of lectin binding with cells and a cyto-
toxic action of the Les-1895 conjugates with 
these lectins. This suggestion is in agreement 
with our preliminary results on the binding of 
specific lectins with histological specimens of 
the human adenocarcinoma colon cells com-
pared to the cells of normal colon tissue [5].
Thus, the conjugation of Les-1895 with the 
pea and peanut lectins increased the antineo-
plastic activity of the resulting conjugates in 
the T-lymphoblastic leukemia Jurkat cells and 
human adenocarcinoma HCT 116 cells. At the 
same time, the pseudonormal HEK 293 line 
cells were insensitive to the action of tested 
lectins and their conjugates with Les-1895. 
The human adenocarcinoma HCT 116 cells 
were 2-fold more sensitive to the action of 
studied conjugates of lectins and tested com-
pound. According to the literary data [7-9], an 
increased toxicity of conjugates towards tumor 
cells could be caused by a selective binding of 
specific lectins to the carbohydrate-containing 
receptors of the plasma membrane of cells. 
The HSA-Les-1895 conjugate was not toxic 
for the T-lymphoblastic leukemia Jurkat cells 
and only slightly toxic for the human adeno-
carcinoma HCT 116 cells, comparing to a high 
toxicity of the conjugates of Les-1895 with the 
lectins. A cytotoxic action of conjugates Les-
1895 with lectins towards the pseudonormal 
cells HEK 293 line was manifested after 72 h 
only at high doses of the conjugates. Thus, the 
action of the conjugates was more pronounced 
for the adenocarcinoma HCT 116 cells than 
for the pseudonormal cells HEK 293 line 
(Fig. 6). 
We had no the pseudonormal colon cells in 
our collection, thus, we used the human em-
bryonic kidney cells that possess a similar 
structure of the glycoconjugates on their sur-
face [10, 11]. Comparing to tumor cells, these 
cells have a significantly less amount of ter-
minal sialic acids in the plasma membrane [12]. 
Lectins could interact specifically with the 
individual cell surface glycoconjugates creat-
ing an increased local concentration of bound 
substances. As noted in the Introduction sec-
tion, using lectins as medicines has certain 
limitations. They can be used only externally 
at treatment of patients with diseases of skin, 
digestive tract, nasopharynx, lungs, or in the 
rinses and sprays, suppositoria and ointment 
bases. Lectin-containing medicines cannot be 
recommended for administration into the 
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bloodstream because of possible allergic reac-
tions. However, their inclusion in the ointment 
or utilizing in suppositories may be helpful for 
the treatment of colorectal cancer. 
Conclusions
1. Covalent attachment of the thiopyrano[2,3-
d]thiazole derivatives to proteins (lectins) is 
accompanied by an increased solubility of 
A
 
B
Fig. 6. The results of measuring viability (MTT assay) of Les-1895, specific lectins, and their conjugates towards the 
pseudonormal human embryonic kidney HEK 293 cells and the human colorectal carcinoma HCT 116 cells. 
* p < 0.05; ** p<0.01; *** p<0.001
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Fig. 5. The results of measuring cytotoxicity (Trypan blue exclusion test) of Les-1895, specific lectins, and their con-
jugates towards the pseudonormal human embryonic kidney HEK 293 cells.
* p < 0.05; ** p<0.01; *** p<0.001
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formed conjugates in water, however, such 
conjugation does not guarantee an enhacement 
of the biological activity of the attached li-
gands.
2. Native lectins exhibit more pronounced 
cytotoxic action on specific tumor cells, than 
on the pseudonormal cells, and a degree of 
such action depends on the carbohydrate spec-
ificity. Conjugation of lectins with a low mo-
lecular weight ligand posessing antitumor ac-
tivity leads to an increase in the cytotoxicity 
of the resulting conjugates.
3. The cytotoxic effect of Les-1895 conju-
gates with lectin, which selectively binds to 
the HCT 116 human intestinal cancers, was 
dose-dependent. At the same time the effect of 
the developed conjugates of lectins towards 
the pseudonormal human embryonic kidney 
HEK 293 cells was more pronounced after 
24 h, although it was manifested only at high 
doses of the conjugates.
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Використання лектинів як векторних молекул 
для доставки лікарських засобів до клітин 
і тканин. Повідомлення 2
В. О. Антонюк, Н. Р. Скорохід, А. В. Лозинський, 
Р. В. Антонюк, Р. Б. Лесик, Р. С. Стойка
Мета. Визначення на культурі клітин біологічної актив-
ності кон’югатів сполуки з протипухлинною активністю 
з лектинами різної вуглеводної специфічності, де 
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кон’югати використовували як векторні молекули для 
адресної доставки цих речовин. Методи. Кон’югування 
лектинів (насіння гороху (PSA), арахісу (PNA) та ери-
троаглютиніну з насіння квасолі звичайної (PHA-E) з 
похідним тіопірано[2,3-d]тіазолу Les-1895). 
Біотестування цих кон’югатів на культурі клітин різно-
го походження Результати. Кон’югування сполуки 
Les-1895 з лектинами призводить до збільшення її ци-
тотоксичних ефектів щодо клітин Jurkat на 23 % для 
PSA-Les-1895, на 34 % — для PNA-Les-1895 і на 
12 % — для PHA-E-Les-1895. IC50 для кон’юґатів Les-
1895 було ≈ 10 мкг/мл, тоді як для нативного Les-1895 
≈ 30 мкг/мл. Кон’югати Les-1895 з PNA та PHA-E при-
гнічують життєздатність клітин лінії HCT 116 значно 
сильніше, ніж аналогічний кон’югат з PSA. 
Цитотоксична дія кон’югатів з PNA (IC50 = 4 мкг/мл) і 
PHA-E(IC50 = 3 мкг/мл) на ці клітини була сильнішою, 
ніж дія вільного Les-1895 (IC50 = 10 мкг/мл) та інтактних 
лектинів. Приєднання Les-1895 до альбуміну сироватки 
крові людини (HSA) підвищує розчинність Les-1895 у 
воді, однак, на відміну від кон’югатів Les-1895 з лекти-
нами, знижує на 40 % цитотоксичний ефект утвореного 
кон’югату, зокрема, для клітин лінії Jurkat. Псевдо нор-
маль ні клітини лінії HEK 293 виявилися мало чутливи-
ми до дії нативних лектинів PSA, PNA і PHA-E та до 
кон’юґатів цих лектинів. Висновки. Кон’югування 
сполуки Les-1895 із специфічними лектинами посилює 
цитотоксичний ефект. Одержані результати є важливи-
ми для моделювання адресної доставки біологічно ак-
тивних речовин в специфічні клітини тканин організму. 
К л юч ов і  с л ов а: лектин насіння гороху, лектин 
арахісу, ФГА-Р, кон’югати, тіопірано[2,3-d]тіазоли, 
протипухлинна активність
Использование лектинов как векторной 
молекулы для доставки лекарственных средств 
в клетки и ткани. Сообщение 2
В. О. Антонюк, Н. Р. Скорохид, А. В. Лозинский, 
Р. В. Антонюк, Р. Б. Лесык, Р. С. Стойка
Цель. Определение на культуре клеток биологической 
активности конъюгатов соединения с противоопухо-
левой активностью с лектинами различной углеводной 
специфичности, где конъюгаты использовали в каче-
стве векторных молекул для адресной доставки этих 
веществ. Методы. Конъюгирование лектинов (семян 
гороха (PSA), арахиса (PNA) и эритроагглютинина из 
семян фасоли обыкновенной (PHA-E) из производным 
тиопирано[2,3-d]тиазола Les-1895). Биотестирование 
этих конъюгатов на культуре клеток различного про-
исхождения. Результаты. Конъюгирование соедине-
ния Les-1895 с лектинами приводит к увеличению 
цитотоксических эффектов конъюгата для клеток 
Jurkat на 23 % для PSA-Les-1895, на 34 % — для PNA-
Les-1895 и на 12 % — для PHA-E-Les -1895. IC50 для 
конъюгатов Les-1895 было ≈ 10 мкг/мл, тогда как для 
нативного Les-1895 ≈ 30 мкг/мл. Конъюгаты Les-1895 
с PNA и PHA-E подавляют жизнеспособность клеток 
линии HCT 116 значительно сильнее, чем аналогичный 
конъюгат с PSA. Цитотоксическое действие 
конъюгатов c PNA (IC50 = 4 мкг/мл) и PHA-E (IC50 = 
3 мкг/мл) на эти клетки было сильнее, чем действие 
свободного Les-1895 (IC50 = 10 мкг/мл) и интактных 
лектинов. Присоединение Les-1895 к альбумину 
сыворотки крови человека (HSA) повышает раство-
римость Les-1895 в воде, однако, в отличие от 
конъюгатов Les-1895 с лектинами, цитотоксический 
эффект образованного конъюгата снижается на 40 %, 
в частности, для клеток линии Jurkat. Псевдо нор маль-
ные клетки линии HEK 293 оказались мало чувст-
вительными к действию нативных лектинов PSA, PNA 
и PHA-E и к действию конъюгатов этих лектинов. 
Выводы. Конъюгирование Les-1895 со специфичес-
кими лектинами усиливает цитотоксический эффект. 
Полученные результаты показывают возможность 
адресной доставки биологически активных веществ 
в специфические клетки, ткани и органы тела чело-
века.
К л юч е в ы е  с л ов а: лектин семян гороха, лектин 
арахиса, ФГА-Р, коньюґаты, тиопирано[2,3-d]тиазолы, 
противоопухолевая активность
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